Annual Accounts Payable
$5.04 M
+$2.54 M+101.26%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual accounts payable is $5.04 million, with the most recent change of +$2.54 million (+101.26%) on December 31, 2023.
- CYTH annual accounts payable is now at all-time high.
Performance
CYTH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.02 M
+$1.16 M+30.14%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly accounts payable is $5.02 million, with the most recent change of +$1.16 million (+30.14%) on September 30, 2024.
- Over the past year, CYTH quarterly accounts payable has increased by +$166.60 thousand (+3.43%).
- CYTH quarterly accounts payable is now at all-time high.
Performance
CYTH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CYTH Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +101.3% | +3.4% |
| 3 y3 years | - | +3.4% |
| 5 y5 years | - | +3.4% |
CYTH Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.3% | at high | +124.9% |
| 5 y | 5-year | at high | +101.3% | at high | +124.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Cyclo Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.02 M(+30.1%) |
| Jun 2024 | - | $3.86 M(+5.2%) |
| Mar 2024 | - | $3.67 M(-24.4%) |
| Dec 2023 | $5.04 M(+101.3%) | $4.86 M(+117.4%) |
| Dec 2022 | $2.51 M(+165.7%) | $2.23 M(-23.8%) |
| Jun 2021 | - | $2.93 M(-34.3%) |
| Sep 2020 | - | $4.46 M(+169.4%) |
| Sep 2018 | - | $1.65 M(+28.4%) |
| Jun 2018 | - | $1.29 M(+29.8%) |
| Mar 2018 | - | $993.10 K(+5.3%) |
| Dec 2017 | $943.00 K(+175.3%) | $943.00 K(+73.0%) |
| Sep 2017 | - | $545.20 K(+146.7%) |
| Mar 2017 | - | $221.00 K(-35.5%) |
| Dec 2016 | $342.50 K(+364.7%) | $342.50 K(+360.3%) |
| Sep 2008 | - | $74.40 K(+29.2%) |
| Jun 2008 | - | $57.60 K(-37.7%) |
| Mar 2008 | - | $92.50 K(+25.5%) |
| Dec 2007 | $73.70 K(+41.2%) | $73.70 K(+244.4%) |
| Sep 2007 | - | $21.40 K(+56.2%) |
| Jun 2007 | - | $13.70 K(-69.1%) |
| Mar 2007 | - | $44.30 K(-15.1%) |
| Dec 2006 | $52.20 K | $52.20 K(+21.1%) |
| Sep 2006 | - | $43.10 K(-10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $47.90 K(-57.5%) |
| Mar 2006 | - | $112.60 K(+300.7%) |
| Dec 2005 | $28.10 K(+18.1%) | $28.10 K(+7.3%) |
| Sep 2005 | - | $26.20 K(+87.1%) |
| Jun 2005 | - | $14.00 K(-55.6%) |
| Mar 2005 | - | $31.50 K(+32.4%) |
| Dec 2004 | $23.80 K(-48.0%) | $23.80 K(+12.3%) |
| Sep 2004 | - | $21.20 K(-18.8%) |
| Jun 2004 | - | $26.10 K(-58.0%) |
| Mar 2004 | - | $62.10 K(+35.6%) |
| Dec 2003 | $45.80 K(+97.4%) | $45.80 K(+53.7%) |
| Sep 2003 | - | $29.80 K(+65.6%) |
| Jun 2003 | - | $18.00 K(-42.1%) |
| Mar 2003 | - | $31.10 K(+34.1%) |
| Dec 2002 | $23.20 K(-84.8%) | $23.20 K(-63.6%) |
| Sep 2002 | - | $63.80 K(-42.3%) |
| Jun 2002 | - | $110.60 K(-7.6%) |
| Mar 2002 | - | $119.70 K(-21.5%) |
| Dec 2001 | $152.40 K(-16.4%) | $152.40 K(+10.8%) |
| Sep 2001 | - | $137.50 K(-18.3%) |
| Jun 2001 | - | $168.30 K(-16.6%) |
| Mar 2001 | - | $201.90 K(+10.7%) |
| Dec 2000 | $182.40 K | $182.40 K(-3.0%) |
| Sep 2000 | - | $188.10 K |
FAQ
- What is Cyclo Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual accounts payable year-on-year change?
- What is Cyclo Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly accounts payable year-on-year change?
What is Cyclo Therapeutics annual accounts payable?
The current annual accounts payable of CYTH is $5.04 M
What is the all time high annual accounts payable for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual accounts payable is $5.04 M
What is Cyclo Therapeutics annual accounts payable year-on-year change?
Over the past year, CYTH annual accounts payable has changed by +$2.54 M (+101.26%)
What is Cyclo Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CYTH is $5.02 M
What is the all time high quarterly accounts payable for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly accounts payable is $5.02 M
What is Cyclo Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CYTH quarterly accounts payable has changed by +$166.60 K (+3.43%)